Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis. (2017)
Attributed to:
Autologous Macrophage Therapy for Liver Cirrhosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2017.05.009
PubMed Identifier: 28673774
Publication URI: http://europepmc.org/abstract/MED/28673774
Type: Journal Article/Review
Volume: 19
Parent Publication: Cytotherapy
Issue: 9
ISSN: 1465-3249